Press releaseBusiness Wire
Spruce Biosciences
SPRB · NASDAQ
$41.23+$0.83 (+2.05%)TodayMarket closed ·
Prev close $40.40
Latest news
- Press releaseBusiness Wire
Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
- Press releaseBusiness Wire
Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Press releaseBusiness Wire
Spruce Biosciences Announces Launch of MPS3BStudy.com
- Press releaseBusiness Wire
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
- Press releaseBusiness Wire
Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
- Press releaseBusiness Wire
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
- Press releaseBusiness Wire
Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development
- Press releaseBusiness Wire
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
- Press releaseBusiness Wire
Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
- Press releaseBusiness Wire
Spruce Biosciences Joins the Russell 3000® Index
- Press releaseBusiness Wire
Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs
- Press releaseBusiness Wire
Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller
- Press releaseBusiness Wire
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium
- Press releaseBusiness Wire
Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
- Press releaseBusiness Wire
Spruce Biosciences to Participate in Upcoming Conferences in June
- Press releaseBusiness Wire
Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
- Press releaseBusiness Wire
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
Stock Market Today: Dow Jones, S&P 500 Futures Edge Higher With Eyes On Iran Talks—Apple, UnitedHealth, 3M In Focus (UPDATED)
- NewsAkanksha Bakshi
Why Is Spruce Biosciences Stock Sinking Tuesday?
- Press releaseBusiness Wire
Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
- Press releaseBusiness Wire
Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Press releaseBusiness Wire
Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates
- Press releaseBusiness Wire
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer
- Press releaseBusiness Wire
Spruce Biosciences to Present at Upcoming Investor Conferences in March
- Press releaseBusiness Wire
Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
- Press releaseBusiness Wire
Spruce Biosciences to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- NewsVandana Singh
Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences
- NewsAvi Kapoor
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- NewsMohd Haider
Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why
- NewsAvi Kapoor
Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge
- NewsAlex Perry
Spruce Biosciences Stock Is Soaring Today: Here's Why
- NewsAvi Kapoor
US Stocks Mixed; Dow Falls 100 Points
- NewsAvi Kapoor
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
- NewsAvi Kapoor
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Crude Oil Moves Lower; Citigroup Posts Upbeat Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.